• Embryos to ERs: LifeAire’s Clean Air Revolution
    Mar 4 2026

    Send a text

    A career in IVF led Dr. Kathryn C. Worrilow to a surprising discovery: “clean” spaces can still fail when air chemistry shifts at parts-per-billion levels. She explains how that breakthrough led to a five-stage approach designed to remediate both VOCs and biological pathogens without producing byproducts. We also explore how that embryo breakthrough is moving into ERs, ORs, NICUs, senior living, and airports.

    LinkedIn

    Company Website


    See More ChalkTalkJim Episodes




    Show More Show Less
    26 mins
  • Healthcare Reform Beyond Politics: A Practical Blueprint
    Feb 19 2026

    Send a text

    Dr. Anaita Dua makes the case that healthcare can unite rather than divide if leaders focus on outcomes, data, and execution. She explains why people across ideologies can align on foundational fixes: transparency, accountability, prevention, and better access. The episode blends policy strategy, clinical insight, and real-world examples to show how the U.S. can build a stronger, healthier middle ground.

    LinkedIn


    See More ChalkTalkJim Episodes




    Show More Show Less
    42 mins
  • Human Touch in an AI Driven Healthcare World
    Feb 11 2026

    Send a text

    This conversation dives into one of healthcare’s biggest tensions: efficiency through AI versus the human relationships patients expect.

    Tim explains where technology can improve workflows and where people remain essential, especially in emotionally sensitive moments.

    The discussion also covers how healthcare organizations can use AI as an enhancer, not a replacement, while protecting patient trust and long-term value.

    Company Website

    Tim Boyle LinkedIn


    See More ChalkTalkJim Episodes




    Show More Show Less
    29 mins
  • Functional Precision Medicine Beyond the Standard of Care
    Feb 4 2026

    Send us a text

    Jim Foote explains why cancer treatment still relies on tradition more than biology, and how functional testing of a patient’s own tumor can change that.

    We unpack his decision support approach that ranks drugs and combinations by sensitivity, the clinical evidence and validation behind it, and the practical realities of getting results into oncologists’ hands when time, toxicity, and payer rules all collide.

    Connect with Jim on LinkedIn

    Explore the First Ascend Biomedical Website


    See More ChalkTalkJim Episodes




    Show More Show Less
    34 mins
  • Healthcare's Highest Return Investment Is Children
    Jan 13 2026

    Send us a text

    Bluebird Kids Health CEO Chris Johnson makes the economic and moral case for investing in pediatric primary care for Medicaid populations. Drawing parallels between caring for frail seniors and serving healthy children, he explains why predictable wellness visits, combined with proactive population health management, can transform community outcomes. Chris discusses locating clinics in pediatric care deserts, measuring success through net promoter scores rather than billing codes, and advocating for children's health in changing policy landscapes.

    Bluebird Kids Health website.

    Chris Johnson LinkedIn


    See More ChalkTalkJim Episodes




    Show More Show Less
    23 mins
  • When Patients Cannot Afford To Get Well
    Dec 2 2025

    Send us a text

    What happens when people simply cannot afford to use the insurance they technically have? Gary Johnson from Qurate unpacks the quiet crisis of patient responsibility, rising deductibles, and expiring ACA subsidies. We explore how this crushes families, destabilizes hospital margins, and forces hard choices about who gets care and when, plus how better financial access models can change the trajectory.




    See More ChalkTalkJim Episodes




    Show More Show Less
    43 mins
  • How Self-Funded Employers Win At Healthcare
    Nov 18 2025

    Send us a text

    Attorney and Phia Group CEO Adam Russo breaks down what it really takes for self-funded employers to “win” at healthcare.

    He explains how to use claims data as a strategic asset, design more innovative benefit plans, avoid stop-loss landmines, and turn employees into engaged healthcare consumers.

    Adam also shares practical incentive programs and direct primary care strategies that have delivered free healthcare and 97% retention in his own company.

    LinkedIn



    See More ChalkTalkJim Episodes




    Show More Show Less
    43 mins
  • How Bio Access Cuts Burn And Time To Data
    Nov 4 2025

    Send us a text

    Julio Martinez Clark breaks down how Bio Access helps founders protect their burn rate while getting to first in human data faster. He explains why time to site activation matters more than line item budgets, how to think about patient recruitment in emerging markets, and what inexperienced PhD and physician founders usually overlook when they try to manage overseas trials without an expert clinical operations partner.

    Podcast

    LinkedIN




    See More ChalkTalkJim Episodes




    Show More Show Less
    32 mins